Search for: "MAJOR PHARMACEUTICALS"
Results 341 - 360
of 4,370
Sort by Relevance
|
Sort by Date
25 Aug 2022, 8:32 am
Before we get to that, we’ll discuss the NLJ’s methodology, which pored through hundreds of entries from plaintiffs firms across the country: The awards recognize law firms’ outstanding plaintiffs work in a high-stakes bench or jury trial or in a major settlement. [read post]
24 Aug 2022, 4:00 am
If behaviour management means using the litigation process to give a defendant and other defendants an education of their responsibilities and is something more or different than just punishment for bad behaviour, the pharmaceutical companies are already heavily regulated and do not need an education about their legal responsibilities by a class action that will yield little to no compensation for the overwhelming majority of the class and ends up being little more than a licensing… [read post]
18 Aug 2022, 1:04 pm
The CDC plays in a major role in that by sharing what it knows about the short and long term dangers of the infectious diseases we face. [read post]
15 Aug 2022, 2:35 pm
Senate Majority Leader Chuck Schumer (D-NY), and U.S. [read post]
14 Aug 2022, 6:12 pm
Tisi has been a nationally recognized trial and appellate lawyer with extensive experience litigating mass tort, pharmaceutical, medical device, and major personal injury cases. [read post]
9 Aug 2022, 5:53 pm
In effect, the majority opinion became the dissent, and the dissent the majority. [read post]
7 Aug 2022, 9:15 am
But in Novartis Pharmaceuticals v. [read post]
7 Aug 2022, 9:15 am
But in Novartis Pharmaceuticals v. [read post]
4 Aug 2022, 7:53 pm
Conference Highlights Include: Preeminent members of the nation’s Food and Drug bar will drill you in the essentials of FDA law and regulation and help you: COMPREHEND the structure of FDA and the roles of the three major agency centers: CDER, CBER, and CDHR MASTER the basics of the application and approval processes for drugs and biologics APPRECIATE the complexities of pharmaceutical IP and the regulatory balance between brand name and generic products… [read post]
4 Aug 2022, 7:14 am
The responses were mixed, with a majority of respondents in the life sciences sector generally disposed favorably to existing judicial tests for patent eligibility. [read post]
4 Aug 2022, 6:17 am
Lipella Pharmaceuticals also registered, becoming the twelfth SIC 2834 (Pharmaceutical Preparations) preliminary filer of 2022. [read post]
Eligibility of Computer-Implemented Inventions Behind Unprecedented Numbers of Patent Office Rulings
2 Aug 2022, 7:49 pm
Historically, the overwhelming majority of decisions have related to inter partes proceedings, such as patent oppositions. [read post]
29 Jul 2022, 3:33 pm
Corrupt pharmaceutical companies, like Purdue Pharma and Insys Therapeutics that prioritize profits over patient care and safety, have exasperated the opioid epidemic. [read post]
29 Jul 2022, 4:51 am
This provision allows Medicare to negotiate drug prices with pharmaceutical companies and caps out-of-pocket costs for those on Medicare at $2,000 per year. [read post]
26 Jul 2022, 9:10 pm
But, despite the new law, current rules do encourage voluntary transactions involving, for example, active pharmaceutical ingredients. [read post]
26 Jul 2022, 1:24 am
Finally, the Patent Listing section of the Orange Book addresses some of the major issues FDA wrestled with in adopting the 2016 rules implementing the Medicare Modernization Act of 2003. [read post]
25 Jul 2022, 12:45 pm
A common example is a grant to a pharmaceutical company to develop a drug for public benefit that might otherwise not be commercially viable. [read post]
25 Jul 2022, 3:58 am
CBP’s Green Trade Strategy has two major prongs. [read post]
21 Jul 2022, 1:36 am
Consequently, PTO is “prioritizing” various initiatives to strengthen the patent system for both the pharmaceutical industry and other technologies. [read post]
14 Jul 2022, 7:01 am
And it would force American investors and firms to disclose new investments in certain sensitive sectors such as semiconductors, batteries, and pharmaceuticals. [read post]
